Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Oncology Letters
      • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Biomedical Reports
      • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • Information for Authors
    • Information for Reviewers
    • Information for Librarians
    • Information for Advertisers
    • Conferences
  • Language Editing
Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • For Authors
    • For Reviewers
    • For Librarians
    • For Advertisers
    • Conferences
  • Language Editing
Login Register Submit
  • This site uses cookies
  • You can change your cookie settings at any time by following the instructions in our Cookie Policy. To find out more, you may read our Privacy Policy.

    I agree
Search articles by DOI, keyword, author or affiliation
Search
Advanced Search
presentation
International Journal of Molecular Medicine
Join Editorial Board Propose a Special Issue
Print ISSN: 1107-3756 Online ISSN: 1791-244X
Journal Cover
July-2020 Volume 46 Issue 1

Full Size Image

Sign up for eToc alerts
Recommend to Library

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

Medicine International

An International Open Access Journal Devoted to General Medicine.

Journal Cover
July-2020 Volume 46 Issue 1

Full Size Image

Sign up for eToc alerts
Recommend to Library

  • Article
  • Citations
    • Cite This Article
    • Download Citation
    • Create Citation Alert
    • Remove Citation Alert
    • Cited By
  • Similar Articles
    • Related Articles (in Spandidos Publications)
    • Similar Articles (Google Scholar)
    • Similar Articles (PubMed)
  • Download PDF
  • Download XML
  • View XML
Article Open Access

EOFAZ inhibits endothelial‑to‑mesenchymal transition through downregulation of KLF4

  • Authors:
    • Yanyan Zhang
    • Chen Li
    • Yongpan Huang
    • Shuang Zhao
    • Yini Xu
    • Yan Chen
    • Feng Jiang
    • Ling Tao
    • Xiangchun Shen
  • View Affiliations / Copyright

    Affiliations: The State Key Laboratory of Functions and Applications of Medicinal Plants, School of Basic Medical Sciences, Guizhou Medical University, Guiyang, Guizhou 550025, P.R. China, Department of Clinical Pharmacy, School of Pharmaceutical Sciences, Guizhou Medical University, Guiyang, Guizhou 550025, P.R. China
    Copyright: © Zhang et al. This is an open access article distributed under the terms of Creative Commons Attribution License.
  • Pages: 300-310
    |
    Published online on: April 9, 2020
       https://doi.org/10.3892/ijmm.2020.4572
  • Expand metrics +
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )
Cited By (CrossRef): 0 citations Loading Articles...

This article is mentioned in:



Abstract

Essential oil from Alpinia zerumbet rhizome (EOFAZ), which is termed Yan shanjiang in China, is extensively used as an herbal medicine in the Guizhou area and has been shown to protect against the damaging effects of cardiovascular injury in vitro and in vivo. In the present study, it was hypothesized that the protective effects of EOFAZ on transforming growth factor (TGF)‑β1‑induced endothelial‑to‑mesenchymal transition (EndMT) in human umbilical vein endothelial cells (HUVECs) were mediated by inhibition of Krüppel‑like factor 4 (KLF4). Cell motility was assessed using wound healing and Transwell assays. The expression of endothelial markers and mesenchymal markers were determined by reverse transcription‑quantitative PCR, immunofluorescence staining and western blotting, and additionally, phosphorylated NF‑κB p65 expression was determined by western blotting. Furthermore, the involvement of KLF4 in EndMT was determined using RNA interference to knockdown the expression of KLF4. TGF‑β1 treatment significantly promoted EndMT, as evidenced by downregulation of vascular endothelial‑cadherin and upregulation of α‑smooth muscle actin in HUVECs, and by enhancing cell migration. Small interfering RNA‑mediated knockdown of KLF4 reversed TGF‑β1‑induced EndMT. Additionally, treatment with EOFAZ inhibited TGF‑β1‑induced EndMT in a dose‑dependent manner. These results suggest that TGF‑β1 may induce EndMT through upregulation of KLF4, and this may be reversed by EOFAZ. Therefore, EOFAZ was shown to inhibit TGF‑β1‑induced EndMT through regulation of KLF4.
View Figures

Figure 1

Figure 2

Figure 3

Figure 4

Figure 5

Figure 6

View References

1 

Chen Q, Zhang H, Liu Y, Adams S, Eilken H, Stehling M, Corada M, Dejana E, Zhou B and Adams RH: Endothelial cells are progenitors of cardiac pericytes and vascular smooth muscle cells. Nat Commun. 7:124222016. View Article : Google Scholar : PubMed/NCBI

2 

Gibbons GH and Dzau VJ: The emerging concept of vascular remodeling. N Engl J Med. 330:1431–1438. 1994. View Article : Google Scholar : PubMed/NCBI

3 

Davis GE and Senger DR: Endothelial extracellular matrix: Biosynthesis, remodeling, and functions during vascular morphogenesis and neovessel stabilization. Circ Res. 97:1093–1107. 2005. View Article : Google Scholar : PubMed/NCBI

4 

Karimi Galougahi K, Ashley EA and Ali ZA: Redox regulation of vascular remodeling. Cell Mol Life Sci. 73:349–363. 2016. View Article : Google Scholar

5 

Zhang B, Niu W, Dong HY, Liu ML, Luo Y and Li ZC: Hypoxia induces endothelial-mesenchymal transition in pulmonary vascular remodeling. Int J Mol Med. 42:270–278. 2018.PubMed/NCBI

6 

Jackson AO, Zhang J, Jiang Z and Yin K: Endothelial-to-mesenchymal transition: A novel therapeutic target for cardiovascular diseases. Trends Cardiovasc Med. 27:383–393. 2017. View Article : Google Scholar : PubMed/NCBI

7 

Zhang L, Li YM, Zeng XX, Wang XY, Chen SK, Gui LX and Lin MJ: Galectin-3-mediated transdifferentiation of pulmonary artery endothelial cells contributes to hypoxic pulmonary vascular remodeling. Cell Physiol Biochem. 51:763–777. 2018. View Article : Google Scholar

8 

Wesseling M, Sakkers TR, de Jager SCA, Pasterkamp G and Goumans MJ: The morphological and molecular mechanisms of epithelial/endothelial-to-mesenchymal transition and its involvement in atherosclerosis. Vascul Pharmacol. 106:1–8. 2018. View Article : Google Scholar : PubMed/NCBI

9 

Zhang Y, Wu X, Li Y, Zhang H, Li Z, Zhang Y, Zhang L, Ju J, Liu X, Chen X, et al: Endothelial to mesenchymal transition contributes to arsenic-trioxide-induced cardiac fibrosis. Sci Rep. 6:337872016. View Article : Google Scholar : PubMed/NCBI

10 

Tian D, Zeng X, Wang W, Wang Z, Zhang Y and Wang Y: Protective effect of rapamycin on endothelial-to-mesenchymal transition in HUVECs through the Notch signaling pathway. Vascul Pharmacol. 113:20–26. 2018. View Article : Google Scholar : PubMed/NCBI

11 

Kanasaki K, Taduri G and Koya D: Diabetic nephropathy: The role of inflammation in fibroblast activation and kidney fibrosis. Front Endocrinol (Lausanne). 4:72013. View Article : Google Scholar

12 

Xiong J, Kawagishi H, Yan Y, Liu J, Wells QS, Edmunds LR, Fergusson MM, Yu ZX, Rovira II, Brittain EL, et al: A metabolic basis for endothelial-to-mesenchymal transition. Mol Cell. 69:689–698.e7. 2018. View Article : Google Scholar : PubMed/NCBI

13 

Yu QC, Song W, Wang D and Zeng YA: Identification of blood vascular endothelial stem cells by the expression of protein C receptor. Cell Res. 26:1079–1098. 2016. View Article : Google Scholar : PubMed/NCBI

14 

Cooley BC, Nevado J, Mellad J, Yang D, St Hilaire C, Negro A, Fang F, Chen G, San H, Walts AD, et al: TGF-β signaling mediates endothelial-to-mesenchymal transition (EndMT) during vein graft remodeling. Sci Transl Med. 6:227ra342014. View Article : Google Scholar

15 

Vanchin B, Offringa E, Friedrich J, Brinker MG, Kiers B, Pereira AC, Harmsen MC, Moonen JA and Krenning G: MicroRNA-374b induces endothelial-to-mesenchymal transition and early lesion formation through the inhibition of MAPK7 signaling. J Pathol. 247:456–470. 2019. View Article : Google Scholar :

16 

Suzuki T, Carrier EJ, Talati MH, Rathinasabapathy A, Chen X, Nishimura R, Tada Y, Tatsumi K and West J: Isolation and characterization of endothelial-to-mesenchymal transition cells in pulmonary arterial hypertension. Am J Physiol Lung Cell Mol Physiol. 314:L118–L126. 2018. View Article : Google Scholar :

17 

Li J, Xiong J, Yang B, Zhou Q, Wu Y, Luo H, Zhou H, Liu N, Li Y, Song Z and Zheng Q: Endothelial cell apoptosis induces TGF-β signaling-dependent host endothelial-mesenchymal transition to promote transplant arteriosclerosis. Am J Transplant. 15:3095–3111. 2015. View Article : Google Scholar : PubMed/NCBI

18 

Wang J, Yan G, Guo H, Zhu Y, Shui X, He Y, Chen C and Lei W: ITE promotes hypoxia-induced transdifferentiation of human pulmonary arterial endothelial cells possibly by activating transforming growth factor-β/Smads and MAPK/ERK pathways. J Cell Biochem. 120:19567–19577. 2019. View Article : Google Scholar : PubMed/NCBI

19 

Zuo XX, Yang Y, Zhang Y, Zhang ZG, Wang XF and Shi YG: Platelets promote breast cancer cell MCF-7 metastasis by direct interaction: Surface integrin α2β1-contacting-mediated activation of Wnt-β-catenin pathway. Cell Commun Signal. 17:1422019. View Article : Google Scholar

20 

Shen XC, Tao L, Li WK, Zhang YY, Luo H and Xia YY: Evidence-based antioxidant activity of the essential oil from fructus A. Zerumbet on cultured human umbilical vein endothelial cells' injury induced by ox-LDL. BMC Complement Altern Med. 12:1742012. View Article : Google Scholar : PubMed/NCBI

21 

Tao L, Hu HS and Shen XC: Endothelium-dependent vasodilatation effects of the essential oil from Fructus alpiniae zerumbet (EOFAZ) on rat thoracic aortic rings in vitro. Phytomedicine. 20:387–393. 2013. View Article : Google Scholar : PubMed/NCBI

22 

Chen Y, Li D, Xu Y, Zhang Y, Tao L, Li S, Jiang Y and Shen X: Essential oils from fructus A. Zerumbet protect human aortic endothelial cells from apoptosis induced by Ox-LDL in vitro. Evid Based Complement Alternat Med. 2014:9568242014. View Article : Google Scholar

23 

Yob NJ, Jofrry SM, Affandi MM, The LK, Salleh MZ and Zakaria ZA: Zingiber zerumbet (L.) Smith: A review of its ethnomedicinal, chemical, and pharmacological uses. Evid Based Complement Alternat Med. 2011:5432162011. View Article : Google Scholar : PubMed/NCBI

24 

Chompoo J, Upadhyay A, Fukuta M and Tawata S: Effect of Alpinia zerumbet components on antioxidant and skin diseases-related enzymes. BMC Complement Altern Med. 12:1062012. View Article : Google Scholar : PubMed/NCBI

25 

de Moura RS, Emiliano AF, de Carvalho LC, Souza MA, Guedes DC, Tano T and Resende AC: Antihypertensive and endothelium-dependent vasodilator effects of Alpinia zerumbet, a medicinal plant. J Cardiovasc Pharmacol. 46:288–294. 2005. View Article : Google Scholar : PubMed/NCBI

26 

Linghu K, Lin D, Yang H, Xu Y, Zhang Y, Tao L, Chen Y and Shen X: Ameliorating effects of 1,8-cineole on LPS-induced human umbilical vein endothelial cell injury by suppressing NF-κB signaling in vitro. Eur J Pharmacol. 789:195–201. 2016. View Article : Google Scholar : PubMed/NCBI

27 

Yang H, Fang Z, Qu X, Zhang X and Wang Y: Procyanidin compound (PC) suppresses lipopolysaccharide-induced cervical cancer cell proliferation through blocking the TLR4/NF-κB pathway. Cancer Manag Res. 12:497–509. 2020. View Article : Google Scholar :

28 

Shu Y, Liu Y, Li X, Cao L, Yuan X, Li W and Cao Q: Aspirin-triggered resolvin D1 inhibits TGF-β1-induced EndMT through increasing the expression of Smad7 and is closely related to oxidative stress. Biomol Ther (Seoul). 24:132–139. 2016. View Article : Google Scholar

29 

Mahler GJ, Farrar EJ and Butcher JT: Inflammatory cytokines promote mesenchymal transformation in embryonic and adult valve endothelial cells. Arterioscler Thromb Vasc Biol. 33:121–130. 2013. View Article : Google Scholar :

30 

Yoshida T, Yamashita M, Iwai M and Hayashi M: Endothelial Krüppel-like factor 4 mediates the protective effect of statins against ischemic AKI. J Am Soc Nephrol. 27:1379–1388. 2016. View Article : Google Scholar

31 

Cuttano R, Rudini N, Bravi L, Corada M, Giampietro C, Papa E, Morini MF, Maddaluno L, Baeyens N, Adams RH, et al: KLF4 is a key determinant in the development and progression of cerebral cavernous malformations. EMBO Mol Med. 8:6–24. 2016. View Article : Google Scholar :

32 

Zhou Z, Tang AT, Wong WY, Bamezai S, Goddard LM, Shenkar R, Zhou S, Yang J, Wright AC, Foley M, et al: Cerebral cavernous malformations arise from endothelial gain of MEKK3-KLF2/4 signalling. Nature. 532:122–126. 2016. View Article : Google Scholar : PubMed/NCBI

33 

Huang N, Xu Y, Zhou H, Lin D, Zhang B, Zhang Y, Pan D, Tao L, Liu X and Shen X: Essential oil from fructus alpiniae zerumbet protects human umbilical vein endothelial cells in vitro from injury induced by high glucose levels by suppressing nuclear transcription factor-kappa B signaling. Med Sci Monit. 23:4760–4767. 2017. View Article : Google Scholar : PubMed/NCBI

34 

Wu M, Liu L, Xing Y, Yang S, Li H and Cao Y: Roles and mechanisms of hawthorn and its extracts on atherosclerosis: A review. Front Pharmacol. 11:1182020. View Article : Google Scholar : PubMed/NCBI

35 

Yu W, Liu Z, An S, Zhao J, Xiao L, Gou Y, Lin Y and Wang J: The endothelial-mesenchymal transition (EndMT) and tissue regeneration. Curr Stem Cell Res Ther. 9:196–204. 2014. View Article : Google Scholar : PubMed/NCBI

36 

Cruz-Solbes AS and Youker K: Epithelial to mesenchymal transition (EMT) and endothelial to mesenchymal transition (EndMT): Role and implications in kidney fibrosis. Results Probl Cell Differ. 60:345–372. 2017. View Article : Google Scholar : PubMed/NCBI

37 

Pardali E, Sanchez-Duffhues G, Gomez-Puerto MC and Ten Dijke P: TGF-β-induced endothelial-mesenchymal transition in fibrotic diseases. Int J Mol Sci. 18:pii: E2157. 2017. View Article : Google Scholar

38 

Hao YM, Yuan HQ, Ren Z, Qu SL, Liu LS, Dang H, Yin K, Fu M and Jiang ZS: Endothelial to mesenchymal transition in atherosclerotic vascular remodeling. Clin Chim Acta. 490:34–38. 2019. View Article : Google Scholar

39 

Geng H and Guan J: MiR-18a-5p inhibits endothelial-mesen-chymal transition and cardiac fibrosis through the Notch2 pathway. Biochem Biophys Res Commun. 491:329–336. 2017. View Article : Google Scholar : PubMed/NCBI

40 

Chen XY, Lv RJ, Zhang W, Yan YG, Li P, Dong WQ, Liu X, Liang ES, Tian HL, Lu QH and Zhang MX: Inhibition of myocyte-specific enhancer factor 2A improved diabetic cardiac fibrosis partially by regulating endothelial-to-mesenchymal transition. Oncotarget. 7:31053–31066. 2016. View Article : Google Scholar : PubMed/NCBI

41 

Guan S and Zhou J: CXCR7 attenuates the TGF-β-induced endothelial-to-mesenchymal transition and pulmonary fibrosis. Mol Biosyst. 13:2116–2124. 2017. View Article : Google Scholar : PubMed/NCBI

42 

Akhurst RJ: Targeting TGF-β signaling for therapeutic gain. Cold Spring Harb Perspect Biol. 9:pii: a022301. 2017. View Article : Google Scholar

43 

Bakhta O, Blanchard S, Guihot AL, Tamareille S, Mirebeau-Prunier D, Jeannin P and Prunier F: Cardioprotective role of colchicine against inflammatory injury in a rat model of acute myocardial infarction. J Cardiovasc Pharmacol Ther. 23:446–455. 2018. View Article : Google Scholar : PubMed/NCBI

44 

Wetzel-Strong SE, Detter MR and Marchuk DA: The pathobiology of vascular malformations: Insights from human and model organism genetics. J Pathol. 241:281–293. 2017. View Article : Google Scholar

45 

Fu Y, Chang A, Chang L, Niessen K, Eapen S, Setiadi A and Karsan A: Differential regulation of transforming growth factor beta signaling pathways by Notch in human endothelial cells. J Biol Chem. 284:19452–19462. 2009. View Article : Google Scholar : PubMed/NCBI

46 

Cunha SI, Magnusson PU, Dejana E and Lampugnani MG: Deregulated TGF-β/BMP signaling in vascular malformations. Circ Res. 121:981–999. 2017. View Article : Google Scholar : PubMed/NCBI

47 

Ghaleb AM and Yang VW: Krüppel-like factor 4 (KLF4): What we currently know. Gene. 611:27–37. 2017. View Article : Google Scholar : PubMed/NCBI

48 

McConnell BB, Ghaleb AM, Nandan MO and Yang VW: The diverse functions of Krüppel-like factors 4 and 5 in epithelial biology and pathobiology. Bioessays. 29:549–557. 2007. View Article : Google Scholar : PubMed/NCBI

49 

Zhang Y, Lam O, Nguyen MT, Ng G, Pear WS, Ai W, Wang IJ, Kao WW and Liu CY: Mastermind-like transcriptional co-activator-mediated Notch signaling is indispensable for maintaining conjunctival epithelial identity. Development. 140:594–605. 2013. View Article : Google Scholar : PubMed/NCBI

50 

Wang Y, Yang C, Gu Q, Sims M, Gu W, Pfeffer LM and Yue J: KLF4 promotes angiogenesis by activating VEGF signaling in human retinal microvascular endothelial cells. PLoS One. 10:e01303412015. View Article : Google Scholar : PubMed/NCBI

51 

Ji L, Zhao G, Zhang P, Huo W, Dong P, Watari H, Jia L, Pfeffer LM, Yue J and Zheng J: Knockout of MTF1 inhibits the epithelial to mesenchymal transition in ovarian cancer cells. J Cancer. 9:4578–4585. 2018. View Article : Google Scholar : PubMed/NCBI

Related Articles

  • Abstract
  • View
  • Download
  • Twitter
Copy and paste a formatted citation
Spandidos Publications style
Zhang Y, Li C, Huang Y, Zhao S, Xu Y, Chen Y, Jiang F, Tao L and Shen X: EOFAZ inhibits endothelial‑to‑mesenchymal transition through downregulation of KLF4. Int J Mol Med 46: 300-310, 2020.
APA
Zhang, Y., Li, C., Huang, Y., Zhao, S., Xu, Y., Chen, Y. ... Shen, X. (2020). EOFAZ inhibits endothelial‑to‑mesenchymal transition through downregulation of KLF4. International Journal of Molecular Medicine, 46, 300-310. https://doi.org/10.3892/ijmm.2020.4572
MLA
Zhang, Y., Li, C., Huang, Y., Zhao, S., Xu, Y., Chen, Y., Jiang, F., Tao, L., Shen, X."EOFAZ inhibits endothelial‑to‑mesenchymal transition through downregulation of KLF4". International Journal of Molecular Medicine 46.1 (2020): 300-310.
Chicago
Zhang, Y., Li, C., Huang, Y., Zhao, S., Xu, Y., Chen, Y., Jiang, F., Tao, L., Shen, X."EOFAZ inhibits endothelial‑to‑mesenchymal transition through downregulation of KLF4". International Journal of Molecular Medicine 46, no. 1 (2020): 300-310. https://doi.org/10.3892/ijmm.2020.4572
Copy and paste a formatted citation
x
Spandidos Publications style
Zhang Y, Li C, Huang Y, Zhao S, Xu Y, Chen Y, Jiang F, Tao L and Shen X: EOFAZ inhibits endothelial‑to‑mesenchymal transition through downregulation of KLF4. Int J Mol Med 46: 300-310, 2020.
APA
Zhang, Y., Li, C., Huang, Y., Zhao, S., Xu, Y., Chen, Y. ... Shen, X. (2020). EOFAZ inhibits endothelial‑to‑mesenchymal transition through downregulation of KLF4. International Journal of Molecular Medicine, 46, 300-310. https://doi.org/10.3892/ijmm.2020.4572
MLA
Zhang, Y., Li, C., Huang, Y., Zhao, S., Xu, Y., Chen, Y., Jiang, F., Tao, L., Shen, X."EOFAZ inhibits endothelial‑to‑mesenchymal transition through downregulation of KLF4". International Journal of Molecular Medicine 46.1 (2020): 300-310.
Chicago
Zhang, Y., Li, C., Huang, Y., Zhao, S., Xu, Y., Chen, Y., Jiang, F., Tao, L., Shen, X."EOFAZ inhibits endothelial‑to‑mesenchymal transition through downregulation of KLF4". International Journal of Molecular Medicine 46, no. 1 (2020): 300-310. https://doi.org/10.3892/ijmm.2020.4572
Follow us
  • Twitter
  • LinkedIn
  • Facebook
About
  • Spandidos Publications
  • Careers
  • Cookie Policy
  • Privacy Policy
How can we help?
  • Help
  • Live Chat
  • Contact
  • Email to our Support Team